Advertisement

Topics

Human Epidermal Growth Factor receptor EGF R - Biotech, Pharma and Life Science Channel

08:57 EST 12th December 2018 | BioPortfolio

The human epidermal growth factor receptor (HER) family members include EGFR (erbB1), HER2/neu (erbB2), HER3 (erbB3), and HER4 (erbB4) that are structurally related, and all except HER3 contain intracellular tyrosine kinase (tk) domain. All of the HER members, except HER2, bind to extracellular ligands

EGFR, a valid target in many epithelial malignancies, is a transmembrane protein with an extracellular ligand binding domain joined to an intracellular tyrosine kinase domain. Activation of EGFR induces a cascade of downstream signaling through several pathways, such as mitogenac tivated protein kinase (MAPK) and PI3-kinase / Akt/mTOR, resulting in cellular proliferation, differentiation, survival, motility, adhesion, and repair. EGFR is overexpressed or abnormally activated in several epithelial malignancies. Several antibodies targeting EGF-R and small molecules inhibiting the EGF-R tyrosine kinase have been approved and are used for treatment of colorectal cancer, squamous cell cancer of the head & neck or pancreatic cancer, respectively. EGF-R targeting therapeutics achieved 2008 sales of US$ 3.35 bln.

The pipeline of novel EGF-R targeting molecules is rather full and includes novel antibody as well as vaccine approaches and small molecules with a broader inhibition profile. At least six next generation antibodies against EGF-R are already in clinical development and more than ten biologics are preclinical R&D including dual target antibodies or vaccines. The small molecule pipeline is focused on dual EGF-R and Her2 as well as pan-Her tk inhibitors, but also includes multi-target EGF-R tk inhibitors.

Source; ReportLinker - Competitor Analysis: EGF-R Agonists and Antagonists

Add the Human Epidermal Growth Factor receptor news channel to your RSS reader;

News Articles [4623 Associated News Articles listed on BioPortfolio]

Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing

Expanded Leadership Team and Funding Supports Advancement of Clinical Development of Checkmate’s TLR9 Agonist, CMP-001 Checkmate Pharmaceuticals Inc., a clinical stage bioph...

Casma Therapeutics Strengthens Leadership Team with Appointment of Chief Operating Officer, Vice President of People & Culture

Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced the appointment of two senior execut...

AVEO Oncology Announces Immuno-Oncology Clinical Collaboration with AstraZeneca

Phase 1/2 Study will Evaluate Combination of IMFINZI® (durvalumab) and FOTIVDA® (tivozanib) in First-Line HCC AVEO Oncology (NASDAQ: AVEO) today announced that it has...

As part of our functional genomics approach, we focus on developing #CRISPR to better understand cancer biology, creating biological models that aim to more accurately reflect human disease. Learn more: http://bit.ly/2Pv9aT1 . @sangerinstitute @CRUKRese

As part of our functional genomics approach, we focus on developing #CRISPR to better understand cancer biology, creating biological models that aim to more accurately reflect human disease. Learn mo...

PatientPop Publishes Comprehensive Practice Growth Playbook

Healthcare providers can use the playbook to master local search marketing and get found online. PatientPop, the market leader in practice growth technology, has releas...

TissueGen Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryTissueGen Inc TissueGen is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company's products comprise pharmaceutical fibe...

United States Crown and Bridge Materials Market Outlook to 2025 [Report Updated: 04092018] Prices from USD $4246

United States Crown and Bridge Materials Market Outlook to 2025SummaryGlobalData's new report, United States Crown and Bridge Materials Market Outlook to 2025, provides key market data on the United S...

EU5 Anesthesia Machines Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $5096

EU5 Anesthesia Machines Market Outlook to 2025SummaryGlobalData's new report, EU5 Anesthesia Machines Market Outlook to 2025, provides key market data on the EU5 Anesthesia Machines market. The report...

Mexico Anesthesia and Respiratory Procedures Outlook to 2025 Airway and Anesthesia Procedures, Regional Anesthesia Procedures and Respiratory Procedures [Report Updated: 01102018] Prices from USD $3396

Mexico Anesthesia and Respiratory Procedures Outlook to 2025 Airway and Anesthesia Procedures, Regional Anesthesia Procedures and Respiratory ProceduresSummaryGlobalData's new report, Mexico Anesthes...

Australia Dental Lasers Market Outlook to 2025 [Report Updated: 01092018] Prices from USD $4246

Australia Dental Lasers Market Outlook to 2025SummaryGlobalData's new report, Australia Dental Lasers Market Outlook to 2025, provides key market data on the Australia Dental Lasers market. The report...

Events [0 Results]

None

Companies [811 Associated Companies listed on BioPortfolio]

iCell Gene Therapeutics, LLC

iCell Gene Therapeutics, located in Stony Brook, New York, is a clinical-stage biotechnology company developing first-in-class chimeric antigen receptor engineered cells. Clinical...

Triumvira Immunologics Inc.

Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

Battelle and Canopy Growth Corporation

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle condu...

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically ...

Akebia Therapeutics, Inc. and Keryx Biopharmaceuticals, Inc.

Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease th...

Harvest Health & Recreation Inc.

Harvest Health & Recreation Inc. (CSE:HARV) is a vertically integrated cannabis company with permits and licenses in 10 U.S. states (including local approvals in Massachusetts). H...

UF Innovate | The Hub

UF Innovate | The Hub is a University of Florida business incubator with a mission to build, drive and support innovation. The incubator is recognized as a major catalyst i...

Human Health Organization

FSD Pharma Inc. FSD Pharma Inc.

FSD Pharma is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatmen...

Clinical Trials [9531 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate Letrozole, Pyrotinib Combined With SHR6390 in Patients With HR+/HER2+ Relapsed/Metastatic Breast Cancer

This is a single-center Ib / II study of triple targeted drug combination (aromatase inhibitor letrozole,novel HER2-targeted small molecule inhibitor pyrotinib and CDK4/6 inhibitor SHR63...

Postprandial Response of Individuals to Dietary Inorganic Phosphate

The study aims to compare the postprandial response of plasma phosphate and cardiometabolic relevant factors to phosphate intake in defined diet(s).

KP-10 and Insulin Secretion in Men

Induction of insulin secretion by kisspeptin is observed in mouse, pig, rat, and human islets in vitro (Bowe et al., 2012) and in rats, mice (Bowe et al., 2009) and monkeys in vivo (Wahab ...

Oral Factor XIa Inhibitor for the Prevention of New Ischemic Stroke in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stro...

Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children

Visual development during early childhood is a vital process. Examining the visual acuity of children is essential for the early detection of visual abnormality, but performing such an ass...

Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase

A randomised controlled open-label clinical trial to compare the outcome parameters after ovarian stimulation using recombinant-human FSH (follicle stimulating hormone), starting on day 2 ...

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

The aim of this study is to identify risk factors and prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria colonization among patients at high risk of STIs

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Primary Objective: To demonstrate that the simple daily titration algorithm is non-inferior to the weekly titration algorithm according to Canadian labeling. Secondary Objective: ...

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

This study is for patients that are having a bone marrow or stem cell transplant for either a type of cancer of the blood called Leukemia or a cancer of the lymph nodes called Non-Hodgkin'...

GLP-1 Receptor Expression in CHI

The primary objective is the in vivo and ex vivo investigation of the expression and distribution of the GLP-1R in the pancreas of CHI patients.

PubMed Articles [26113 Associated PubMed Articles listed on BioPortfolio]

Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer.

It is known that disorders in apoptosis function play an important role in the pathogenesis of many types of cancer, including lung cancer. Tumor necrosis factor related apoptosis inducing ligand (TRA...

Seroprevalence of Heartland Virus Antibodies in Blood Donors, Northwestern Missouri, USA.

We estimated the seroprevalence of Heartland virus antibodies to be 0.9% (95% CI 0.4%-4.2%) in a convenience sample of blood donors from northwestern Missouri, USA, where human cases and infected tick...

Optimization of sample preparation procedures for evaluation of the mineral composition of fish feeds using ICP-based methods.

This work describes the application of an experimental design in optimizing the decomposition and spectrometer operational conditions for analysis of fish feeds. The content of 22 elements (six macroe...

Attenuated Total Reflectance Fourier Transform Spectroscopy (ATR-FTIR) and chemometrics for discrimination of espresso coffees with different sensory characteristics.

Coffee cup quality, determined by the sensory attributes evaluated by professional tasters, is a decisive factor for evaluating coffee, with the "Specialty Coffee Association of America" (SCAA) classi...

Thermal rice oil degradation evaluated by UV-Vis-NIR and PARAFAC.

Thermal rice oil degradation was evaluated by UV-Vis and NIR in three-way arrays assembled with samples, different temperatures, and the absorbance at different wavelengths by applying PARAFAC chemome...

Validation of a LC/MSMS method for simultaneous quantification of 9 nucleotides in biological matrices.

Nucleotides play a role in inflammation processes: cAMP and cGMP in the endothelial barrier function, ADP in platelet aggregation, ATP and UTP in vasodilatation and/or vasoconstriction of blood vessel...

Development and evaluation of a novel in situ target-capture approach for aptamer selection of human noroviruses.

Human noroviruses (HuNoVs) is the primary non-bacterial pathogen causing acute gastroenteritis worldwide. Molecular approaches have been mainly used for detection of HuNoVs. Aptamer-based assay has be...

Optimization of the post-acquisition data processing for the non-targeted screening of trace leachable residues from reusable plastic bottles by high performance liquid chromatography coupled to hybrid quadrupole time of flight mass spectrometry.

Food safety regulations for food contact materials (FCM) usually rely on the assessment of chemical migration in order to reduce human exposure to chemical residues that could leach from the FCM into ...

First characterizations by capillary electrophoresis of human Chorionic Gonadotropin at the intact level.

In the present work, the first characterizations by Capillary Electrophoresis of the human Chorionic Gonadotropin (hCG) hormone at the intact level were carried out. hCG is a hetero-dimeric glycoprote...

Graphene nanoplatelets in potentiometry: A nanocomposite carbon paste and PVC based membrane sensors for analysis of Vilazodone HCl in plasma and milk samples.

Graphene is the ''new star'' material for electrochemical sensing. It has unique mechanical, thermal and electrical properties, in addition to its ultra light weight. In the present work we combine fo...

Videos

None available.

Medical and Biotech [MESH] Definitions

A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF related peptides including TRANSFORMING GROWTH FACTOR ALPHA, amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.

A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. EPIDERMAL GROWTH FACTOR exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and epithelial cells.

A fibroblast growth factor that preferentially activates FIBROBLAST GROWTH FACTOR RECEPTOR 4. It was initially identified as an androgen-induced growth factor and plays a role in regulating growth of human BREAST NEOPLASMS and PROSTATIC NEOPLASMS.

A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in APERT SYNDROME.

A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF Receptor (RECEPTOR, EPIDERMAL GROWTH FACTOR) and the erbB-2 receptor (RECEPTOR, ERBB-2). Overexpression of the erbB-3 receptor is associated with tumorigenesis.

Advertisement
Quick Search
Advertisement
Advertisement

 
review and buy Human Epidermal Growth Factor receptor EGF R market research data and corporate reports here

Channels Quicklinks